Benoit Bestgen

5 Avenue Du Grand Sablon
La Tronche, 38700, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

New Malaria Prevention Modalities: Long-Acting Interventions Beyond Vaccines.

New Malaria Prevention Modalities: Long-Acting Interventions Beyond Vaccines.

Journal: Cold Spring Harbor perspectives in medicine

Published: June 29, 2026

The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria.

The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria.

Journal: Science translational medicine

Published: June 10, 2026

First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.

First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.

Journal: British journal of clinical pharmacology

Published: October 04, 2024

First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.

First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.

Journal: British journal of clinical pharmacology

Published: October 04, 2024

Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection study.

Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection study.

Journal: The Lancet. Infectious diseases

Published: August 13, 2024

4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.

4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.

Journal: European journal of medicinal chemistry

Published: April 22, 2020

Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.

Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.

Journal: Scientific reports

Published: May 15, 2019

2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.

2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.

Journal: Journal of medicinal chemistry

Published: January 29, 2019

2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.

2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.

Journal: Journal of medicinal chemistry

Published: January 29, 2019

In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface.

In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 25, 2016

Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors.

Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors.

Journal: Journal of medicinal chemistry

Published: March 25, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026